A conserved uORF regulates APOBEC3G translation and is targeted by HIV-1 Vif protein to repress the antiviral factor
ABSTRACT The HIV-1 Vif protein is essential for viral fitness and pathogenicity. Vif decreases expression of cellular restriction factors APOBEC3G (A3G), A3F, A3D and A3H, which inhibit HIV-1 replication by inducing hypermutation during reverse transcription. Vif counteracts A3G at several levels (transcription, translation and protein degradation) that together reduce the levels of A3G in cells and prevent its incorporation into viral particles. How Vif affects A3G translation remains unclear. Here, we uncovered the importance of a short conserved uORF (upstream ORF) located within two critical stem-loop structures of the 5’ untranslated region (5’UTR) of A3G mRNA for this process. A3G translation occurs through a combination of leaky-scanning and translation re-initiation and the presence of an intact uORF decreases the extent of global A3G translation under normal conditions. Interestingly, the uORF is also absolutely required for Vif-mediated translation inhibition and redirection of A3G mRNA into stress granules. Overall, we discovered that A3G translation is regulated by a small uORF conserved in the human population and that Vif uses this specific feature to repress its translation..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
bioRxiv.org - (2022) vom: 25. Mai Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Libre, Camille [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1101/2021.01.13.426487 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI019729022 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI019729022 | ||
| 003 | DE-627 | ||
| 005 | 20230429074758.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210115s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2021.01.13.426487 |2 doi | |
| 035 | |a (DE-627)XBI019729022 | ||
| 035 | |a (biorXiv)10.1101/2021.01.13.426487 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 570 |q DE-84 | |
| 100 | 1 | |a Libre, Camille |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A conserved uORF regulates APOBEC3G translation and is targeted by HIV-1 Vif protein to repress the antiviral factor |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT The HIV-1 Vif protein is essential for viral fitness and pathogenicity. Vif decreases expression of cellular restriction factors APOBEC3G (A3G), A3F, A3D and A3H, which inhibit HIV-1 replication by inducing hypermutation during reverse transcription. Vif counteracts A3G at several levels (transcription, translation and protein degradation) that together reduce the levels of A3G in cells and prevent its incorporation into viral particles. How Vif affects A3G translation remains unclear. Here, we uncovered the importance of a short conserved uORF (upstream ORF) located within two critical stem-loop structures of the 5’ untranslated region (5’UTR) of A3G mRNA for this process. A3G translation occurs through a combination of leaky-scanning and translation re-initiation and the presence of an intact uORF decreases the extent of global A3G translation under normal conditions. Interestingly, the uORF is also absolutely required for Vif-mediated translation inhibition and redirection of A3G mRNA into stress granules. Overall, we discovered that A3G translation is regulated by a small uORF conserved in the human population and that Vif uses this specific feature to repress its translation. | ||
| 700 | 1 | |a Seissler, Tanja |e verfasserin |4 aut | |
| 700 | 1 | |a Guerrero, Santiago |e verfasserin |4 aut | |
| 700 | 1 | |a Batisse, Julien |e verfasserin |4 aut | |
| 700 | 1 | |a Verriez, Cédric |e verfasserin |4 aut | |
| 700 | 1 | |a Stupfler, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Gilmer, Orian |e verfasserin |4 aut | |
| 700 | 1 | |a Cabrera-Rodriguez, Romina |e verfasserin |4 aut | |
| 700 | 1 | |a Weber, Melanie M. |e verfasserin |4 aut | |
| 700 | 1 | |a Valenzuela-Fernandez, Agustin |e verfasserin |4 aut | |
| 700 | 1 | |a Cimarelli, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Etienne, Lucie |e verfasserin |4 aut | |
| 700 | 1 | |a Marquet, Roland |e verfasserin |4 aut | |
| 700 | 1 | |a Paillart, Jean-Christophe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2022) vom: 25. Mai |
| 773 | 1 | 8 | |g year:2022 |g day:25 |g month:05 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/biomedicines10010013 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.01.13.426487 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 25 |c 05 | ||
| 953 | |2 045F |a 570 | ||